Key facts
- Aavia’s last known valuation is $17.5M (Jan 2025).
- It has raised $7.2M; the latest was Later Stage VC ($210K) in Jan 2025.
- Notable investors include MassChallenge, Gaingels, Dorm Room Fund, Bantam Group, Seven Seven Six — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Aavia
- ·The full record, as it builds
Funding rounds
No funding rounds for Aavia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aavia
Developer of a health tracker platform designed to manage and learn about hormonal changes. The company's platform helps to take birth control pills on time and track the hormone cycle, also understand how their hormones impact their mood, skin, and sleep among others, enabling females to prevent unwanted healthcare crises.
- Sector
- Consumer Products and Services (B2C)
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 7
- Website
- aavia.io/
- Ownership
- Privately Held (backing)
Aavia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aavia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aavia in its N-PORT filings yet. We sweep new filings monthly.